This webcast features an expert panel discussing the U.S. government’s global response to TB and key challenges in combating the disease around the world.
- view as grid
- view as list
The Kaiser Family Foundation hosts a town hall-style discussion with Ambassador Eric Goosby, the U.S. Global AIDS Coordinator, about the latest developments in the President’s Emergency Plan for AIDS Relief (PEPFAR).
This November 16, 2010, webcast features an expert panel exploring the future of U.S. multilateral engagement on global health. It is part of the Foundation’s U.S. Global Health Policy: In Focus series.
This fact sheet examines federal funding for the global HIV/AIDS epidemic, with a primary emphasis on funding activities that benefit resource poor countries. United States funding for international HIV/AIDS activities in resource poor countries began in the mid-1980s; and in FY 2003, the U.S. Congress appropriated close to $1.5 billion…
This fact sheet presents data on the range of resources currently directed to address the HIV/AIDS epidemic in resource poor settings, including bilateral, multilateral, and private sector support, as well as domestic funding by affected country governments. Fact Sheet (.pdf)
The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.
This April 21 In Focus webcast features an expert panel examining the new legislative landscape of the 112th Congress and what the current budget battles mean for U.S. global health programs.
On Wednesday, June 13, at 12:00 p.m. ET (noon), the Foundation held a live, interactive webcast to examine recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria and the implications for U.S. global health policy. A panel of experts discussed the Global Fund’s recent funding challenges and reorganization,…
This fact sheet examines the key role played by the United States in the Global Fund, an independent, independent, multilateral, financing entity designed to raise significant new resources to combat HIV/AIDS, tuberculosis (TB) and malaria in low- and middle- income countries.